2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
Introduction '''2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a''' ('''HPPH''') is a photosensitiser chemical that is used in photodynamic therapy.It is being developed under the brand name '''Photochlor'''.
Clinical trials A phase I/II clinical trial started in 1997 for esophageal cancer.A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011.==References==
External links *  Clinical trials of HPPH